Private Management Group Inc Gilead Sciences, Inc. Transaction History

Private Management Group Inc

$2.52 Billion
Q1 2025

A detailed history of Private Management Group Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Private Management Group Inc holds 8,381 shares of GILD stock, worth $924,256. This represents 0.04% of its overall portfolio holdings.

Number of Shares

8,381

Previous 211,383 96.04%

Holding current value

$924,256

Previous $19.5 Million 95.19%

% of portfolio

0.04%

Previous 0.79%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$89.14 - $117.41 $18.1 Million - $23.8 Million	-203,002 Reduced 96.04%	8,381 $939,000
Q4 2024 Jan 27, 2025	SELL	$83.95 - $97.9 $17.3 Million - $20.2 Million	-206,514 Reduced 49.42%	211,383 $19.5 Million
Q3 2024 Oct 29, 2024	SELL	$66.59 - $83.99 $2.77 Million - $3.5 Million	-41,661 Reduced 9.07%	417,897 $35 Million
Q2 2024 Aug 06, 2024	BUY	$63.15 - $72.88 $517,324 - $597,032	8,192 Added 1.81%	459,558 $31.5 Million
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $23,335 - $28,456	326 Added 0.07%	451,366 $33.1 Million
Q4 2023 Feb 01, 2024	SELL	$73.27 - $83.09 $122,434 - $138,843	-1,671 Reduced 0.37%	451,040 $36.5 Million
Q3 2023 Oct 30, 2023	BUY	$73.94 - $80.67 $1.94 Million - $2.12 Million	26,226 Added 6.15%	452,711 $33.9 Million
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $520,744 - $593,981	6,851 Added 1.63%	426,485 $32.9 Million
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $207,500 - $236,406	-2,684 Reduced 0.64%	419,634 $34.8 Million
Q4 2022 Feb 02, 2023	SELL	$62.32 - $89.47 $5.63 Million - $8.09 Million	-90,387 Reduced 17.63%	422,318 $36.3 Million
Q3 2022 Feb 06, 2023	BUY	$59.54 - $68.01 $5.38 Million - $6.15 Million	90,387 Added 21.4%	512,705 $31.6 Million
Q3 2022 Feb 06, 2023	BUY	$59.54 - $68.01 $5.38 Million - $6.15 Million	90,387 Added 21.4%	512,705 $31.6 Million
Q3 2022 Nov 08, 2022	SELL	$59.54 - $68.01 $3.98 Million - $4.55 Million	-66,871 Reduced 11.54%	512,705 $31.6 Million
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $49,408 - $55,648	-856 Reduced 0.15%	579,576 $35.8 Million
Q1 2022 May 06, 2022	SELL	$57.92 - $72.58 $227,162 - $284,658	-3,922 Reduced 0.67%	580,432 $34.5 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $748,974 - $850,100	11,544 Added 2.02%	584,354 $42.4 Million
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $100,587 - $108,522	-1,486 Reduced 0.26%	572,810 $40 Million
Q2 2021 Jul 23, 2021	BUY	$63.47 - $69.35 $447,907 - $489,402	7,057 Added 1.24%	574,296 $39.5 Million
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $1.97 Million - $2.25 Million	32,799 Added 6.14%	567,239 $36.7 Million
Q4 2020 Feb 03, 2021	BUY	$56.65 - $64.55 $9.37 Million - $10.7 Million	165,427 Added 44.83%	534,440 $31.1 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $13.1 Million - $16.4 Million	210,477 Added 132.76%	369,013 $23.3 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $11.5 Million - $13.3 Million	158,536 New	158,536 $12.2 Million

Others Institutions Holding GILD

# of Institutions

2,295

Shares Held

Call Options Held

9.59M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $138B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Management Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Private Management Group Inc with notifications on news.

Account

Private Management Group Inc Gilead Sciences, Inc. Transaction History